rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0024884,
umls-concept:C0043210,
umls-concept:C0087111,
umls-concept:C0243088,
umls-concept:C0302350,
umls-concept:C0439611,
umls-concept:C0543419,
umls-concept:C0907857,
umls-concept:C1518601,
umls-concept:C1550456,
umls-concept:C2603343
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-12-20
|
pubmed:abstractText |
Approximately 30% of women who undergo mastectomy without reconstructive treatment due to breast cancer present sequelae. These include paresthesias, keloid healing, hypoesthesia, lymphedema and limitation of the function of the ipsilateral upper extremity. We undertook this study to present the results using collagen-polyvinylpyrrolidone (Clg- Pvp) as treatment for posmastectomy sequelae in women with breast cancer.
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-7411
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-4
|
pubmed:meshHeading |
pubmed-meshheading:21167096-Adult,
pubmed-meshheading:21167096-Aged,
pubmed-meshheading:21167096-Arm,
pubmed-meshheading:21167096-Breast Neoplasms,
pubmed-meshheading:21167096-Cicatrix,
pubmed-meshheading:21167096-Collagen,
pubmed-meshheading:21167096-Dermatologic Agents,
pubmed-meshheading:21167096-Esthetics,
pubmed-meshheading:21167096-Female,
pubmed-meshheading:21167096-Humans,
pubmed-meshheading:21167096-Injections, Subcutaneous,
pubmed-meshheading:21167096-Keloid,
pubmed-meshheading:21167096-Lymph Node Excision,
pubmed-meshheading:21167096-Lymphedema,
pubmed-meshheading:21167096-Mastectomy, Radical,
pubmed-meshheading:21167096-Middle Aged,
pubmed-meshheading:21167096-Paresthesia,
pubmed-meshheading:21167096-Povidone,
pubmed-meshheading:21167096-Prospective Studies,
pubmed-meshheading:21167096-Range of Motion, Articular,
pubmed-meshheading:21167096-Wound Healing
|
pubmed:articleTitle |
[Collagen-polyvinylpyrrolidone: a new therapeutic option for treatment of sequelae after radical mastectomy in women with breast cancer. Preliminary study].
|
pubmed:affiliation |
Departamento de Cirugía Plástica, Hospital General Regional 36, Instituto Mexicano del Seguro Social, Puebla, México. alvaro.montielj@imss.gob.mx
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|